Literature DB >> 7629089

Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor.

C Chen1, J C Xue, J Zhu, Y W Chen, S Kunapuli, J Kim de Riel, L Yu, L Y Liu-Chen.   

Abstract

Binding of beta-funaltrexamine (beta-FNA) to the cloned rat mu opioid receptor expressed in COS-1 cells or Chinese hamster ovary cells was examined. beta-FNA bound to the mu receptor with high affinity. Irreversible binding of [3H]beta-FNA was defined as the binding that could not be dissociated by trichloroacetic acid. Na+ greatly enhanced the specific irreversible binding of [3H]beta-FNA to the mu receptor, which was concentration- and time-dependent. Specific irreversible binding of [3H]beta-FNA was potently inhibited by CTAP (a mu ligand), but not by ICI174,864 (a delta ligand) or U50,488H (a kappa ligand). These results indicate that [3H]beta-FNA binds irreversibly to the cloned mu opioid receptor. SDS-polyacrylamide gel electrophoresis and fluorography showed that [3H]beta-FNA-labeled receptors migrated as one broad and diffuse band with a mass of 80 kDa in Chinese hamster ovary or COS cells and as one band with a mass of 67 kDa in the rat brain preparation. Upon removal of N-linked carbohydrates, labeled receptors became a sharper band with a mass of approximately 40 kDa. [3H]beta-FNA did not bind irreversibly to the cloned rat kappa receptor. [3H]beta-FNA binding to four chimeric mu/kappa receptors was examined. The region from the middle of the third intracellular loop to the C terminus of the mu receptor is necessary for irreversible binding of beta-FNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629089     DOI: 10.1074/jbc.270.30.17866

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.

Authors:  Wei Xu; Chongguang Chen; Jian-Guo Li; Kelly Dimattio; Yujun Wang; Ellen Unterwald; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2013-04-26       Impact factor: 5.037

2.  Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

3.  A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.

Authors:  Peng Huang; Chongguang Chen; Stephen D Mague; Julie A Blendy; Lee-Yuan Liu-Chen
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

4.  Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells.

Authors:  Peng Huang; Wei Xu; Su-In Yoon; Chongguang Chen; Parkson Lee-Gau Chong; Lee-Yuan Liu-Chen
Journal:  Biochem Pharmacol       Date:  2006-11-03       Impact factor: 5.858

5.  Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor "knockdown" in vivo.

Authors:  M Garrido; J Gubbens-Stibbe; E Tukker; E Cox; J von Frijtag; D Künzel; A IJzerman; M Danhof; P H van der Graaf
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

6.  K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA).

Authors:  Kelly M DiMattio; Chongguang Chen; Lei Shi; Lee-Yuan Liu-Chen
Journal:  Eur J Pharmacol       Date:  2014-12-04       Impact factor: 4.432

7.  Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors.

Authors:  Bhaswati Sinha; Zhengyu Cao; Thomas F Murray; Jane V Aldrich
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

8.  Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.

Authors:  S Nijmeijer; H Engelhardt; S Schultes; A C van de Stolpe; V Lusink; C de Graaf; M Wijtmans; E E J Haaksma; I J P de Esch; K Stachurski; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.

Authors:  Enrica Bianchi; Monica Norcini; Alan Smrcka; Carla Ghelardini
Journal:  J Neurochem       Date:  2009-07-27       Impact factor: 5.372

10.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

Authors:  I D Pogozheva; A L Lomize; H I Mosberg
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.